News you can use: health & drug safety updates

2017

  • January 5, 2017

    FDA’s Center for Drug Evaluation and Research (CDER) provides an audio podcast series, The Director’s Corner, featuring discussions by FDA’s CDER director, Janet Woodcock, MD. The latest podcast presents a discussion on various opioid safety labeling changes and opioid prescribing in the US.

  • January 4, 2017
    "The Patient Education Materials Assessment Tool (PEMAT), created by a research team at AHRQ working with a panel of experts in health literacy, content creation, patient education, and communication, is designed to help determine whether patients will be able to effectively use educational resources based on understandability and actionability. PEMAT was designed to be used by healthcare providers, health librarians and others tasked with providing high- quality materials to patients or consumers. There are two versions including PEMAT-P for
  • January 3, 2017

    For the 80 million Americans with high blood pressure, the hectic holiday crunch ’tis the season for a little extra caution. Even people who usually eat healthy diets, exercise and take other precautions may run the risk of sabotaging their health during the holidays. It’s especially important to avoid self-sabotage because of just how dangerous high blood pressure is: It’s a leading risk factor for heart disease and stroke — two of the leading causes of death in the world — and usually has no outward symptoms.

  • January 1, 2017

    NCPIE serves as co-editor for a monthly column in Pharmacy Today (American Pharmacists Association) The column is entitled “One-to-One” and is intended to help develop pharmacists’ medication communication and counseling skills to promote safe and appropriate medicine use.

2016

  • December 21, 2016

    This free, downloadable report provides a nationwide snapshot of expert practices--Comprehensive medication management (CMM) in ambulatory/community pharmacy reveals that clinical pharmacists, in a variety of community and ambulatory care settings, are optimizing medication use and making an impact on the communities they serve. CMM seeks to optimize outcomes through the effective and appropriate use of medications, by focusing on the patient and the clinical and personal goals of therapy. It encompasses all medications and all disease states, so pharmacists

  • December 16, 2016

    Read the latest from the Healthcare Compliance Packaging Council of Europe.

  • December 15, 2016

    The Alliance for Safe Online Pharmacies has launched a new initiative to raise awareness of illegal online drug sellers and counterfeit medications by educating and enlisting the help of healthcare providers across the country. ASOP Global also launched www.BuySafeRx.pharmacy where providers, patients and caregivers can quickly and easily verify whether an Internet pharmacy website is safe and legal. ASOP Global and the Federation of State Medical Boards also

  • December 14, 2016

    FDA is making it easier and faster for health care professionals and patients to get the most up-to-date drug safety information on the more than 18,000 drugs available on our website. Their improved Drug Safety Labeling Changes Program enables FDA to post the latest safety information about a medicine almost at the same time the agency approves a change, as opposed to once a month.

  • December 13, 2016
    A recent study published in Human Factors found that a redesign of medication packages can lead to a decrease in medication errors and accidental overdoses. Tor Endestad, an associate professor in the Department of Psychology at the University of Oslo, and colleagues evaluated user responses to the original packages of generic OTC medication compared with packages that they redesigned several ways. Researchers found that error rates were high with the original packaging but decreased for the redesigned packages: from 41% to 8% among younger users and from 68%
  • December 13, 2016

    A new analysis reveals that 1 in 6 U.S. adults reported taking psychiatric drugs at least once in 2013. Researchers from the Institute for Safe Medication Practices and Risk Sciences International used the 2013 Medical Expenditure Panel Survey to calculate percentages of the adult population using three classes of psychiatric drugs: antidepressants; anxiolytics, sedatives, and hypnotics; and antipsychotics.

Pages